Page 7 - P4304.1-V108_PS Magazine - Apr 25_Neat
P. 7

I embarked on my professional journey with dispensing doctors in 2002
                                     and proudly launched PSUK on April 1st, 2005. PSUK was established
                                     on the solid foundation of the North Yorkshire Emergency Doctors
                                     (NYED) co-operative, with the mission to provide both dispensing and
                                     non-dispensing doctors with exceptional discounts on pharmaceutical
                                     and non-pharmaceutical products. Our strategic partnership with
                                     PHOENIX Healthcare quickly positioned them as our preferred wholesaler,
                                     bolstering our exclusive Manufacturer Discounts Scheme.
                                     In the early days, I faced numerous challenges while expanding PSUK into
                                     new regions such as Suffolk, Shropshire, Cumbria, and Cornwall, initially
                                     serving as the sole salesperson for the group. However, over time, our
                                     team grew. Despite the demands of travel, I relished the opportunity to
                                     explore new places. Given the rural nature of dispensing doctors, I was
                                     fortunate to experience some truly breathtaking scenery.
                                     Our success in growing membership led to PHOENIX acquiring PSUK
                                     in 2007. My role transitioned from director and shareholder to being
                                     part of a larger organisation that could propel PSUK from strength to
                                     strength. Like any business, we encountered challenges, but there were
                                     also abundant opportunities that were fully realised under PHEONIX’s
                                     ownership. Even today, I firmly believe that PSUK holds a competitive edge
                                     over any other buying group. Initiatives like Brand Switch and APM have
                                     created optimal scenarios for our members. While negotiations presented
                                     challenges, transparency and honesty allowed us to overcome them.
                                     I stepped down from my responsibilities at PSUK in 2018, and it was a
                                     pleasure to hand over the reins to Ian Redmond, formerly of GSK. Ian was
                                     an exceptional leader and colleague. After Ian’s retirement in 2021, Simon
                                     Coles took over, and he has been outstanding in leading PSUK. Simon’s
                                     dedication and passion for PSUK is truly remarkable, he is the right
                                     person to adopt my first “baby”.
                                     I often spend time on LinkedIn, and I am always proud to see colleagues
                                     who share the same passion for the business, Julie Darley and
                                     Sarah Sainsbury, both sales managers who have shown unwavering
                                     commitment to PSUK.
                                     I challenge anyone to find a proposition similar to PSUK’s—the loyalty
                                     from our members is extraordinary, thanks to the strong proposition,
                                     service, and support our team provides. While I am not fully aware
                                     of recent changes in the dispensing doctors market, I am conscious
                                     that propositions have evolved. I recommend any dispensing doctor
                                     to explore Golden Tote and consider supporting the dispensing of
                                     a broader portfolio of medicines typically used in hospital settings.
                                     Legacy processes can create inefficiencies, and there are numerous
                                     opportunities to improve.
                                     I recently transitioned into a new role in Europe, focusing on Commercial
                                     Business Development. In this role, I aim to help expand PHOENIX’s
                                     presence and drive growth in key therapies. We are also looking to
                                     enhance the European Strategic Partnership program by strengthening
                                     it through a strong Key Account Management initiative, supported by a
                                     unified CRM platform.
                                     Additionally, as specialty medicine continues to grow faster than
                                     traditional areas, PHOENIX plans to further diversify its offerings to
                                     cover more stages of a pharmaceutical product’s life cycle. This will be
                                     supported by an upstream campaign to reinforce PHOENIX’s position as
                                     a leader in integrated healthcare services across Europe.






                                                                                                   | P
                                                                                                     S M
                                                                                                         a
                                                                                                g
                                                                                                  t
                                                                                                 h
                                                                                                               e
                                                                                                              n
                                                                                                             i
                                                                                                          g
                                                                                                           a
                                                                                                            z
                                                                                        h
                                                                                         e s
                                                                                      n t
               or call us on 01904 558 350                                    MDS Terms Information | PS Magazine     7 7 7 7
                                                                                      I
                                                                                               l
                                                                                               i
                                                                                              t
                                                                                            p
                                                                                             o
                                                                                                                 14/03/2025   16:23:05
         P4304.1-V108_PS Magazine - Apr 25.indd   7                                                              14/03/2025   16:23:05
         P4304.1-V108_PS Magazine - Apr 25.indd   7
   2   3   4   5   6   7   8   9   10   11   12